Immunovant (IMVT) Treasury Shares (2020 - 2026)

Immunovant's Treasury Shares history runs 7 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• Quarterly Treasury Shares changed N/A year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (changed N/A YoY) and the FY2026 annual result came in at $3.5 million, changed N/A from the prior year.
• Treasury Shares was $3.5 million for Q1 2026 at Immunovant, down from $3.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $5.0 million in Q2 2023 and bottomed at $2.7 million in Q1 2022.
• A 5-year average of $3.9 million and a median of $3.8 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 193.11% — and 2024, when it slipped 20.02%.
• Immunovant's Treasury Shares stood at $4.5 million in 2022, then fell by 16.47% to $3.8 million in 2023, then slipped by 6.48% to $3.5 million in 2024, then grew by 9.81% to $3.9 million in 2025, then slipped by 10.29% to $3.5 million in 2026.
• Business Quant data shows IMVT's Treasury Shares at $3.5 million in Q1 2026, $3.9 million in Q4 2025, and $4.3 million in Q3 2025.